Coomb’s Test- Direct and Indirect Coomb’s Test

Coomb’s test, also known as antiglobulin test, is a blood test that detects the presence of antibodies or complement proteins that are bound to the surface of red blood cells (RBCs). These antibodies or complement proteins can cause the RBCs to be destroyed by the immune system, leading to a condition called hemolysis. Hemolysis can result in anemia, jaundice, and other complications.

The main objective of Coomb’s test is to diagnose and monitor hemolytic diseases, such as autoimmune hemolytic anemia, hemolytic disease of the newborn, transfusion reactions, and drug-induced hemolysis. Coomb’s test can also be used to identify certain infections and autoimmune disorders that can cause RBC sensitization.

Coomb’s test is based on the principle that antibodies or complement proteins attached to the RBCs can be detected by adding a reagent called anti-human globulin (AHG), which is an antibody that binds to human antibodies or complement proteins. The AHG causes the sensitized RBCs to clump together (agglutinate), which can be observed under a microscope or by visual inspection.

There are two types of Coomb’s test: direct and indirect. The direct Coomb’s test checks for antibodies or complement proteins that are already attached to the patient’s RBCs in vivo (in the bloodstream). The indirect Coomb’s test checks for antibodies that are floating in the patient’s serum and can attach to RBCs in vitro (in the laboratory).

In this article, we will explain the principle, procedure, interpretation, applications, and limitations of both types of Coomb’s test. We will also provide some examples of medical conditions that can be diagnosed or monitored by Coomb’s test.

The principle of Coomb’s test is based on the detection of antibodies or complement components that are bound to the surface of red blood cells (RBCs). These antibodies or complement components are called sensitizing agents, and they can cause RBCs to agglutinate (clump together) when exposed to a specific reagent called anti-human globulin (AHG) or Coomb’s reagent.

The AHG reagent is a serum that contains antibodies against human immunoglobulins (IgG and IgM) and complement components (C3d and C4d). The AHG reagent can bind to the Fc portion of the sensitizing agents on the RBCs and form a bridge between adjacent RBCs, resulting in agglutination. The agglutination can be observed visually or by using a special device called a cell counter.

The Coomb’s test can be performed in two ways: direct and indirect. The direct Coomb’s test detects sensitizing agents that are already attached to the patient’s RBCs in vivo (in the bloodstream), while the indirect Coomb’s test detects sensitizing agents that are present in the patient’s serum and can attach to normal RBCs in vitro (in the laboratory).

The Coomb’s test is useful for diagnosing various medical conditions that involve RBC sensitization, such as hemolytic anemia, hemolytic disease of the newborn, autoimmune disorders, transfusion reactions, and infections. The Coomb’s test can also help determine the blood group and Rh type of a patient or a donor.

Coombs test is a blood test that detects antibodies or complement proteins that are bound to the surface of red blood cells. These antibodies or complement proteins can cause the red blood cells to be destroyed by the immune system, leading to a condition called hemolytic anemia. Hemolytic anemia can be caused by various factors, such as blood transfusion reactions, autoimmune diseases, infections, drugs, or genetic disorders.

There are two types of Coombs test: the direct Coomb’s test and the indirect Coomb’s test. The direct Coomb’s test checks for antibodies or complement proteins that are already attached to the red blood cells in the patient’s blood sample. The indirect Coomb’s test checks for antibodies that are floating in the patient’s serum (the liquid part of the blood) and can potentially attach to the red blood cells.

The direct Coomb’s test is also known as the direct antiglobulin test (DAT), because it uses an anti-human globulin (AHG) reagent that reacts with the human antibodies or complement proteins on the red blood cells. The indirect Coomb’s test is also known as the indirect antiglobulin test (IAT), because it uses an AHG reagent that reacts with the human antibodies in the serum after they have been incubated with normal red blood cells.

The direct Coomb’s test is used to diagnose conditions where the patient’s own red blood cells are being destroyed by their own antibodies or complement proteins. This is called autoimmune hemolytic anemia. Some examples of autoimmune hemolytic anemia are warm autoimmune hemolytic anemia (WAIHA), cold agglutinin disease (CAD), and paroxysmal cold hemoglobinuria (PCH).

The indirect Coomb’s test is used to diagnose conditions where the patient’s serum contains antibodies that can destroy red blood cells from another person. This can happen in situations such as blood transfusion reactions, hemolytic disease of the newborn (HDN), and alloimmune hemolytic anemia. The indirect Coomb’s test is also used to screen blood donors and recipients for compatibility before a blood transfusion.

Both types of Coombs test are based on the principle of agglutination, which means clumping together of red blood cells. A positive Coomb’s test result means that agglutination has occurred, indicating the presence of antibodies or complement proteins on or against the red blood cells. A negative Coomb’s test result means that no agglutination has occurred, indicating the absence of antibodies or complement proteins on or against the red blood cells.

The following table summarizes the main differences between the direct and indirect Coomb’s tests:

The direct Coomb’s test, also referred to as the direct antiglobulin test (DAT), is used to detect if antibodies or complement system factors have bound to RBCs surface antigens. This test can help diagnose blood-related conditions such as autoimmune hemolytic anemia, where the immune system mistakenly attacks and destroys the red blood cells, leading to anemia .

The principle of the direct Coomb’s test is based on the use of anti-human globulin (AHG) serum, which contains antibodies against human immunoglobulins (IgG) and complement components (C3d). The AHG serum can bind to the antibodies or complement factors that are already attached to the red blood cells, and cause them to agglutinate (clump together). This agglutination can be observed under a microscope or by eye, and indicates a positive result .

The direct Coomb’s test involves the following steps :

• A blood sample is collected from the patient and placed in a tube.
• The red blood cells are washed several times with saline to remove any unbound antibodies or plasma proteins.
• A few drops of AHG serum are added to the tube and mixed well with the red blood cells.
• The tube is centrifuged for a short time and examined for agglutination.
• If no agglutination is seen, a control step is performed by adding pre-sensitized red blood cells (Coombs’ control cells) to the tube. These cells have known antibodies attached to them and should agglutinate with the AHG serum. This confirms that the AHG serum is active and that the result is valid.

A positive direct Coomb’s test means that there are antibodies or complement factors bound to the patient’s red blood cells. This can indicate a condition such as autoimmune hemolytic anemia, hemolytic transfusion reaction, hemolytic disease of the newborn, or drug-induced hemolysis . A negative direct Coomb’s test means that there are no antibodies or complement factors bound to the patient’s red blood cells. This can rule out these conditions, but it does not exclude other causes of anemia .

The indirect Coomb’s test, also known as the indirect antiglobulin test (IAT), is used to detect antibodies that are present in the bloodstream but not attached to the red blood cells. These antibodies could react with foreign red blood cells, such as those from a donor or a fetus, and cause hemolysis (destruction of red blood cells).

The indirect Coomb’s test is used for two main purposes: to screen blood before a transfusion and to check for Rh incompatibility during pregnancy.

• Blood transfusion screening: Before a person receives a blood transfusion, their blood type and Rh factor must be matched with the donor blood to prevent a transfusion reaction. However, sometimes a person may have other antibodies in their serum that are not detected by the routine blood typing tests. These antibodies could be against antigens that are present on some but not all red blood cells of the same blood type. For example, a person with A+ blood may have antibodies against Kell antigen, which is found on some but not all red blood cells with A+ type. If they receive blood from a donor who has Kell antigen on their red blood cells, they could have a hemolytic transfusion reaction.

To prevent this, an indirect Coomb’s test is performed on the recipient’s serum and the donor’s red blood cells. A sample of the recipient’s serum is mixed with a sample of the donor’s red blood cells in a test tube and incubated at 37°C for 30 minutes. Then, anti-human globulin (Coombs reagent) is added to the mixture and centrifuged. If the recipient has antibodies against any of the donor’s red blood cell antigens, they will bind to them and form complexes. The anti-human globulin will then bind to these complexes and cause agglutination (clumping) of the red blood cells. This indicates a positive indirect Coomb’s test and means that the recipient and the donor are not compatible for transfusion.

• Pregnancy testing: During pregnancy, there is a possibility that the mother and the fetus have different blood types or Rh factors. This could cause problems if the mother’s immune system produces antibodies against the fetus’s red blood cells. This condition is called hemolytic disease of the newborn (HDN) or erythroblastosis fetalis and can cause anemia, jaundice, or even death of the fetus or newborn.

To prevent this, an indirect Coomb’s test is performed on the mother’s serum and the father’s or a standard red blood cell sample with known antigens. A sample of the mother’s serum is mixed with a sample of the father’s or standard red blood cells in a test tube and incubated at 37°C for 30 minutes. Then, anti-human globulin (Coombs reagent) is added to the mixture and centrifuged. If the mother has antibodies against any of the father’s or standard red blood cell antigens, they will bind to them and form complexes. The anti-human globulin will then bind to these complexes and cause agglutination (clumping) of the red blood cells. This indicates a positive indirect Coomb’s test and means that the mother and the fetus are at risk of HDN.

The most common cause of HDN is Rh incompatibility, which occurs when the mother has Rh-negative blood and the fetus has Rh-positive blood inherited from the father. The mother may develop anti-Rh antibodies after exposure to Rh-positive blood during delivery, abortion, miscarriage, or amniocentesis. These antibodies can cross the placenta and attack the fetus’s red blood cells in subsequent pregnancies.

To prevent this, Rh-negative mothers are given an injection of Rh immunoglobulin (RhIg) during pregnancy and after delivery. This prevents them from developing anti-Rh antibodies by binding to any Rh-positive red blood cells that may enter their bloodstream.

The indirect Coomb’s test is one of the important tests that can help ensure safe and compatible blood transfusions and healthy pregnancies by detecting potentially harmful antibodies in the serum.

To perform a Coomb’s test, you will need the following materials and equipment:

• Test tubes: These are small glass or plastic tubes that can hold blood samples and reagents. You will need one test tube for each sample and control that you want to test.
• Centrifuge: This is a machine that spins the test tubes at high speed to separate the blood cells from the plasma (the liquid part of the blood).
• Anti-human globulin (AHG) reagent: This is a solution that contains antibodies that can bind to human immunoglobulins (antibodies) on the surface of red blood cells. You will need one drop of AHG reagent for each test tube.
• Pre-sensitized red cells (Coombs’ control cells): These are red blood cells that have been artificially coated with antibodies in the laboratory. You will need one drop of pre-sensitized red cells for each test tube to check the validity of the AHG reagent and the test procedure.
• Saline: This is a sterile solution of salt and water that is used to wash the blood cells and dilute the reagents. You will need enough saline to fill each test tube up to 3/4 of its capacity.

Depending on whether you are performing a direct or an indirect Coomb’s test, you will also need:

• Blood sample: This is a small amount of blood that is drawn from a vein in your arm or from a finger prick. You will need one blood sample for each person or animal that you want to test. For a direct Coomb’s test, you will use the whole blood sample without separating it into plasma and cells. For an indirect Coomb’s test, you will only use the plasma part of the blood sample after centrifuging it.
• Red blood cell suspension: This is a solution that contains red blood cells from a normal donor or from a specific blood group. You will need one drop of red blood cell suspension for each test tube for an indirect Coomb’s test. You can prepare the suspension by mixing one drop of whole blood with nine drops of saline and centrifuging it to remove the plasma.

Before performing the Coomb’s test, you should label each test tube with the name or number of the sample or control that you are testing. You should also store the blood samples, the AHG reagent, and the pre-sensitized red cells in a refrigerator until you are ready to use them.

A direct Coomb’s test (also known as a direct antiglobulin test) is performed on a blood sample taken from a patient by venipuncture. The blood sample is sent to a laboratory or a blood bank, where trained staff follow these steps :

• Prepare a 5% saline suspension of the red blood cells (RBCs) to be tested.
• Add one drop of the RBC suspension to a small test tube and label it as T (test sample).
• Wash the RBCs three to four times with large volumes of saline to remove all traces of serum and decant completely after the last washing.
• Add two drops of anti-human globulin (AHG) serum to the test tube and mix well.
• Centrifuge the test tube at 1500 rpm for one minute and examine for agglutination (clumping) of RBCs by holding it against a lighted background and tapping the bottom of the tube.
• If agglutination is not seen, leave the tube at room temperature for 10 minutes, then re-centrifuge and read. A weaker reacting antibody may show delayed reaction and this is considered positive.
• If agglutination is still not seen, add one drop of pre-sensitized red cells (Coombs’ control cells) to the test tube. This should result in agglutination of the control cells, indicating that the AHG serum is reactive and the result is valid.

A positive direct Coomb’s test means that there are antibodies attached to the patient’s RBCs. A negative direct Coomb’s test means that there are no antibodies attached to the patient’s RBCs.

The indirect Coomb’s test is used to detect antibodies in the serum that can react with red blood cells of a different blood group. The test involves two steps: incubation and detection.

• Incubation: In this step, the serum to be tested is mixed with red blood cells of a known antigen type (such as O-positive) and incubated at 37°C for 30 minutes. This allows any antibodies in the serum to bind to the red blood cells and sensitize them.
• Detection: In this step, the sensitized red blood cells are washed with saline and then mixed with anti-human globulin (AHG) reagent, which is an antibody that recognizes human immunoglobulins. The mixture is centrifuged and examined for agglutination. If agglutination occurs, it means that the serum contains antibodies that react with the red blood cells. This is a positive indirect Coomb’s test. If no agglutination occurs, it means that the serum does not contain such antibodies. This is a negative indirect Coomb’s test.

To confirm the validity of the test, a control step is performed by adding pre-sensitized red blood cells (also called Coomb’s control cells) to the negative test tube. These cells should agglutinate with the AHG reagent, indicating that the reagent is active and the test is reliable.

The indirect Coomb’s test can be modified by using low ionic strength solution (LISS) instead of saline to enhance the antibody binding to the red blood cells. This reduces the incubation time from 30 minutes to 10 minutes.

The Coomb’s test detects agglutination (clumping) of red blood cells. Agglutination occurs when antibodies bind to antigens on the surface of red blood cells and cause them to stick together. The Coomb’s test can be either direct or indirect, depending on whether the antibodies are already attached to the red blood cells or are floating in the bloodstream.

• Direct Coomb’s test: This test looks for antibodies that are attached to the red blood cells. A positive result means that there are antibodies on the red blood cells that may cause hemolysis (destruction of red blood cells). A negative result means that there are no antibodies on the red blood cells or that they are not significant enough to cause hemolysis .
• Indirect Coomb’s test: This test looks for antibodies that are present in the bloodstream but not attached to the red blood cells. A positive result means that there are antibodies in the bloodstream that could potentially attach to red blood cells and cause hemolysis. A negative result means that there are no antibodies in the bloodstream or that they are not significant enough to cause hemolysis .

The interpretation of the Coomb’s test results depends on the clinical context and the reason for performing the test. Some of the possible scenarios are:

• Blood transfusion: The indirect Coomb’s test is used to screen donor and recipient blood for compatibility before a blood transfusion. A positive result means that there is a risk of a transfusion reaction, which can be life-threatening. A negative result means that there is no risk of a transfusion reaction .
• Pregnancy: The indirect Coomb’s test is used to screen pregnant people for Rh sensitization, which can occur when an Rh-negative person carries an Rh-positive fetus. A positive result means that there are antibodies against Rh factor in the bloodstream, which can cross the placenta and harm the fetus. A negative result means that there are no antibodies against Rh factor in the bloodstream .
• Hemolytic anemia: The direct Coomb’s test is used to diagnose hemolytic anemia, which is a condition where red blood cells are destroyed faster than they are produced. A positive result means that there are antibodies on the red blood cells that cause hemolysis. A negative result means that there are no antibodies on the red blood cells or that hemolysis is caused by something else .

A positive Coomb’s test does not necessarily mean that a person has a disease or a condition. It only indicates the presence of antibodies that may or may not cause problems. Likewise, a negative Coomb’s test does not necessarily rule out a disease or a condition. It only indicates the absence of antibodies or their insignificance. Therefore, the Coomb’s test results should always be interpreted along with other clinical findings and laboratory tests .

The Coomb’s test has several applications in the diagnosis and management of various medical conditions that involve antibodies and red blood cells. Some of the main applications are:

• Hemolytic anemia: This is a condition where red blood cells are destroyed faster than they are produced, leading to low levels of hemoglobin and oxygen in the blood. Hemolytic anemia can be caused by autoimmune disorders, infections, drugs, or genetic defects. The direct Coomb’s test can help identify the presence of antibodies on the surface of red blood cells that cause their destruction. The indirect Coomb’s test can help detect antibodies in the serum that can react with red blood cells from a donor or a fetus.
• Blood transfusion: This is a procedure where blood or blood components are given to a person who has lost blood or has a blood disorder. Blood transfusion requires compatibility testing between the donor and the recipient to prevent adverse reactions. The indirect Coomb’s test is used to screen the donor’s blood for antibodies that could harm the recipient’s red blood cells. The direct Coomb’s test is used to monitor the recipient’s blood for signs of hemolysis after transfusion.
• Rh disease: This is a condition where an Rh-negative mother develops antibodies against the Rh-positive red blood cells of her fetus. This can cause hemolytic disease of the newborn (HDN), which can result in jaundice, anemia, or even death of the fetus or newborn. The indirect Coomb’s test is used to screen pregnant women for Rh antibodies and determine the risk of Rh disease. The direct Coomb’s test is used to diagnose HDN in the newborn by detecting antibodies on their red blood cells .
• Other conditions: The Coomb’s test can also be used to detect antibodies in other conditions, such as brucellosis, infectious mononucleosis, syphilis, systemic lupus erythematosus, chronic lymphocytic leukemia, mycoplasmal infection, and drug-induced hemolysis .
  
  

  Limitations of Coomb’s Test

Although Coomb’s test is a useful tool for detecting antibodies that can cause hemolysis or transfusion reactions, it also has some limitations that should be considered :

• Sometimes, especially in older adults, a Coomb’s test will have an abnormal result even without any other disease or risk factors. This may be due to nonspecific binding of antibodies or complement to red blood cells, or the presence of low-affinity antibodies that do not cause clinical problems.
• The test can only be rarely used to diagnose a medical condition by itself. It is usually combined with other tests and clinical findings to confirm a diagnosis or rule out other causes of hemolysis or transfusion reactions.
• The test may not detect all types of antibodies that can cause hemolysis or transfusion reactions. For example, some antibodies may bind to red blood cells only at low temperatures (cold agglutinins) or only in the presence of certain drugs (drug-dependent antibodies). These antibodies may not be detected by the standard Coomb’s test and may require special techniques or reagents.
• The test may give false-positive results due to technical errors or interference from other substances in the blood. For example, testing performed using clotted blood specimens may yield false-positive results with anticomplement. The presence of potent cold autoagglutinins may also interfere with test interpretation. Some drugs, such as cephalosporins, penicillins, and quinidine, may also cause false-positive results by binding to red blood cells or inducing antibody production.
• The test may give false-negative results due to technical errors or insufficient sensitivity of the reagents. For example, testing performed using diluted blood specimens may yield false-negative results with anti-IgG. The use of expired or improperly stored reagents may also affect the test performance. Some antibodies may be present in low concentrations or have low affinity for red blood cells and may not be detected by the standard Coomb’s test.

Therefore, Coomb’s test results should always be interpreted in the context of the clinical situation and other laboratory findings. A negative Coomb’s test does not exclude the possibility of hemolysis or transfusion reactions, and a positive Coomb’s test does not necessarily indicate a clinically significant problem. A repeat test using fresh blood specimens and quality-controlled reagents may be necessary to confirm or exclude a positive or negative result .

We are Compiling this Section. Thanks for your understanding.